EN
CN
EN
About Us
About Viva Biotech
Corporate Culture
History&Awards
Management Team
Environmental, Social and Governance (ESG)
Business Conduct and Ethics
CRO Services
Discovery Biology Services
Protein Expression and Purification
Membrane Protein Targeted Discovery Technology
Ultrasonic Crushing, High Pressure Homogenate Crushing
Affinity Chromatography Purification
Ion Exchange Purification
Gel Filtration Purification
Dialysis, Dilution Refolding
SDS-PAGE, WB, MS, SEC-MALS Detection
Structural Biology Services
X-ray Crystal Structure Analysis of Protein
Cryo-EM Technology Platform
Hit Discovery
Computer-Aided Drug Design
ASMS Technology
SPR Technology
Crystal Soaking Technology
Intact-MS Technology
HTS Technology
Bioassay
Biomolecular Interaction
ASMS Technology
SPR Technology
HDX-MS
Native-MS
Intact-MS
TSA Technology
X-ray Crystal Structure Analysis of Protein
Single-particle Analysis
Microcrystalline Electron Diffraction
Pharmacokinetics
Product Center
Cell-Lines
Crystal Structures
GPCR-Proteins
Antibody
Protein
Chemistry Services
Medicinal Chemistry
Synthetic Chemistry
Analytical Chemistry
Purification Preparation
Chemical Technology Platforms
PROTAC Technology
Polypeptide Technology
Light-catalyzed Reaction
Catalysis Screening Technology
Deuterium and Isotope Modification
Fluorescent Probes and Labeling
Fluorine Chemistry
Macrocyclic Chemistry
Nucleotide Chemistry
Computer-Aided Drug Design
Antibody Drug R&D Services
Antigen Preparation
Discovery of Multi-species Monoclonal Antibodies
Functional Screening and Identification of Antibodies
Antibody Engineering Transformation
Antibody Characteristics
Antibody Cell Line Engineering Transformation
Technology Platforms
Hybridoma
Phage display
Yeast display
Mammalian display
VHH antibody technology
High throughput sequencing
Computer-Aided Drug Design
HDX-MS
Crystal Structure Determination of Protein
SPR Technology
PROTAC/Molecular Glue Services
Protein Preparation and Ternary Complex Structure Determination
Screening for Molecule Glues and Novel E3 Ligase Ligands
PROTAC Ternary Complex Kinetics (SPR)
PROTAC Degradation Assays and Ternary Complex Assays
PROTAC Molecule Design and Synthesis
ADME & PK/PD Studies of PROTAC Molecules
Computer-Aided PROTAC Design
CDMO Services
EFS Business
News
Company News
Events
Portfolio Highlights
Careers
Career Development
Benefits
Employee Care
Investor Relations
Corporate Governance
Information Disclosure
Presentations & Webcasts
IR Newsletter
Investors Contact
Contact Us
News
Company News
Events
Portfolio Highlights
Portfolio Highlights
Year
2023
2022
2021
2020
2019
2018
2017
2016
Month
01
02
03
04
05
06
07
08
09
10
11
12
2022-08-31
Regenacy Pharmaceuticals Announces Completion of Enrollment for Phase 2 Study in Diabetic Peripheral Neuropathy & $9.3 Million Series B Financing
2022-08-10
Arthrosi Completes AR882 Renal Impairment Study
2022-07-28
Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis
2022-07-28
AIxplorerBIO and the Institute of Immunology at Tsinghua University Reached a Strategic Collaboration Agreement to Explore and Promote the R&D of New Drugs in the Field of Autoimmunity
2022-06-30
Domain Therapeutics receives a single digit multimillion development milestone payment from Merck for M1069 clinical development in immuno-oncology
2022-06-28
Portfolio Highlights: Clinical and Financing Updates of Amberstone, Anji, AIxplorerBio, and QurAlis
2022-06-29
Anji Pharma Provides Updates on Two Lead Programs
2022-05-31
QureBio Ltd. to Showcase its Q-1802 Clinical Advances at 2022 ASCO Annual Meetings
2022-05-30
VivaVision and Acemab Reached a Strategic Collaboration Agreement, To Jointly Develop Antibody Drugs For Fundus Diseases
2022-05-26
Portfolio Highlights: Clinical and Financing Updates of Anji, AIxplorerBio, Domain, VivaVision and ArrePath
2022-05-24
Anji Pharma Completes Patient Enrollment in Phase 2 Study of Pradigastat in Functional Constipation
2022-05-18
AIxplorerBio Entered A Broad Collaboration with Baidu’s PaddleHelix to Expedite the Construction of Its AI Small Molecule Drug R&D Platform
<
1
2
3
4
5
6
7
8
>
Media contact:
vivapr@vivabiotech.com
Contact Us
About Us
Back
About Us
About Viva Biotech
Corporate Culture
History&Awards
Management Team
Environmental, Social and Governance (ESG)
Business Conduct and Ethics
CRO Services
Back
CRO Services
Discovery Biology Services
Back
Discovery Biology Services
Protein Expression and Purification
Back
Protein Expression and Purification
Membrane Protein Targeted Discovery Technology
Ultrasonic Crushing, High Pressure Homogenate Crushing
Affinity Chromatography Purification
Ion Exchange Purification
Gel Filtration Purification
Dialysis, Dilution Refolding
SDS-PAGE, WB, MS, SEC-MALS Detection
Structural Biology Services
Back
Structural Biology Services
X-ray Crystal Structure Analysis of Protein
Cryo-EM Technology Platform
Hit Discovery
Back
Hit Discovery
Computer-Aided Drug Design
ASMS Technology
SPR Technology
Crystal Soaking Technology
Intact-MS Technology
HTS Technology
Bioassay
Back
Bioassay
Biomolecular Interaction
Back
Biomolecular Interaction
ASMS Technology
SPR Technology
HDX-MS
Native-MS
Intact-MS
TSA Technology
X-ray Crystal Structure Analysis of Protein
Single-particle Analysis
Microcrystalline Electron Diffraction
Pharmacokinetics
Back
Pharmacokinetics
Product Center
Back
Product Center
Cell-Lines
Crystal Structures
GPCR-Proteins
Antibody
Protein
Chemistry Services
Back
Chemistry Services
Medicinal Chemistry
Synthetic Chemistry
Analytical Chemistry
Purification Preparation
Chemical Technology Platforms
Back
Chemical Technology Platforms
PROTAC Technology
Polypeptide Technology
Light-catalyzed Reaction
Catalysis Screening Technology
Deuterium and Isotope Modification
Fluorescent Probes and Labeling
Fluorine Chemistry
Macrocyclic Chemistry
Nucleotide Chemistry
Computer-Aided Drug Design
Antibody Drug R&D Services
Back
Antibody Drug R&D Services
Antigen Preparation
Discovery of Multi-species Monoclonal Antibodies
Functional Screening and Identification of Antibodies
Antibody Engineering Transformation
Antibody Characteristics
Antibody Cell Line Engineering Transformation
Technology Platforms
Back
Technology Platforms
Hybridoma
Phage display
Yeast display
Mammalian display
VHH antibody technology
High throughput sequencing
Computer-Aided Drug Design
HDX-MS
Crystal Structure Determination of Protein
SPR Technology
PROTAC/Molecular Glue Services
Back
PROTAC/Molecular Glue Services
Protein Preparation and Ternary Complex Structure Determination
Screening for Molecule Glues and Novel E3 Ligase Ligands
PROTAC Ternary Complex Kinetics (SPR)
PROTAC Degradation Assays and Ternary Complex Assays
PROTAC Molecule Design and Synthesis
ADME & PK/PD Studies of PROTAC Molecules
Computer-Aided PROTAC Design
CDMO Services
EFS Business
News
Back
News
Company News
Events
Portfolio Highlights
Careers
Back
Careers
Career Development
Benefits
Employee Care
Investor Relations
Back
Investor Relations
Corporate Governance
Information Disclosure
Presentations & Webcasts
IR Newsletter
Investors Contact
Contact Us